iRhythm gets FDA 510(k) clearance for design modifications to Zio AT device

iRhythm (IRTC) Technologies announced that the U.S. FDA has granted clearance for its 510(k) submission related to design modifications and labeling updates for the Zio AT device. Zio AT remains commercially available on the market to ship to customers in the United States, and product enhancements subject to this 510(k) clearance will be available in 2025.